Mamoru Toyofuku Selected Research

Mamoru Toyofuku Research Topics

Disease

14	Heart Failure 01/2022 - 09/2003
11	Hemorrhage 02/2022 - 01/2019
9	Neoplasms (Cancer) 01/2022 - 11/2017
8	Myocardial Infarction 01/2018 - 11/2006
7	Venous Thromboembolism 02/2022 - 09/2019
7	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 11/2009
5	Aortic Valve Stenosis (Aortic Stenosis) 10/2022 - 01/2019
5	Acute Coronary Syndrome 11/2021 - 12/2010
5	Death (Near-Death Experience) 11/2017 - 09/2008
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 11/2006
4	Anemia 11/2021 - 01/2018
4	Thrombosis (Thrombus) 02/2017 - 09/2008
3	Thromboembolism 11/2019 - 01/2019
3	Chest Pain (Chest Pains) 04/2017 - 06/2013
2	Thrombophilia 01/2022 - 04/2019
2	ST Elevation Myocardial Infarction 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 01/2020
2	Infections 11/2021 - 11/2017
2	Diabetes Mellitus 11/2021 - 01/2021
2	Chronic Renal Insufficiency 01/2021 - 04/2019
2	Acute Aortic Syndrome 10/2020 - 04/2017
2	Pulmonary Embolism 11/2019 - 04/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Hyponatremia 11/2021
1	Ischemic Stroke 11/2021
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Stroke (Strokes) 01/2021
1	Aortic Dissection 10/2020
1	Hypoalbuminemia 01/2020
1	AIDS-Related Complex (ARC) 11/2019
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Shock 12/2018
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2018
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2018
1	Sudden Death 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Hyperemia 05/2015
1	Necrosis 06/2013
1	Stable Angina 01/2012
1	Patent Ductus Arteriosus 09/2011

Drug/Important Bio-Agent (IBA)

4	Adenosine Triphosphate (ATP)IBA 06/2016 - 10/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2019
3	fibrin fragment D (D-dimer)IBA 10/2020 - 04/2017
3	vinyltriethoxysilane (VTES)IBA 11/2019 - 01/2019
3	Adenosine (Adenocard)FDA LinkGeneric 06/2016 - 10/2009
3	omega-Chloroacetophenone (Mace)IBA 01/2011 - 09/2008
2	Hemoglobins (Hemoglobin)IBA 08/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 06/2013
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2019 - 11/2019
2	Nicorandil (SG 75)IBA 06/2016 - 05/2015
2	Sirolimus (Rapamycin)FDA Link 07/2013 - 11/2009
1	Natriuretic PeptidesIBA 10/2022
1	DiureticsIBA 10/2022
1	Heparin (Liquaemin)FDA LinkGeneric 02/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	LipidsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	CrizotinibIBA 01/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2021
1	pro-brain natriuretic peptide (1-76)IBA 11/2021
1	Sodium-Glucose Transport ProteinsIBA 11/2021
1	Cholinesterases (Cholinesterase)IBA 05/2021
1	C-Reactive ProteinIBA 12/2020
1	AlbuminsIBA 01/2020
1	Serum AlbuminIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Streptokinase FDA Link 11/2019
1	Mineralocorticoid Receptor AntagonistsIBA 01/2019
1	regadenoson FDA Link 05/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2015
1	TroponinIBA 06/2013
1	Fatty Acid-Binding ProteinsIBA 06/2013
1	Fatty Acid Binding Protein 3IBA 06/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012
1	Ticlopidine (Ticlid)FDA LinkGeneric 01/2012
1	Adenosine Diphosphate (ADP)IBA 01/2012

Therapy/Procedure

15	Percutaneous Coronary Intervention 01/2022 - 11/2006
8	Therapeutics 02/2022 - 01/2014
8	Stents 01/2022 - 09/2008
4	Transcatheter Aortic Valve Replacement 10/2022 - 01/2019
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2021
3	Drug-Eluting Stents 01/2021 - 01/2011
3	Conservative Treatment 01/2019 - 11/2017
2	Length of Stay 11/2021 - 01/2021
2	Renal Dialysis (Hemodialysis) 01/2018 - 01/2018
1	Extracorporeal Membrane Oxygenation 01/2022
1	Resuscitation 01/2021
1	Secondary Prevention 01/2020
1	Drug Therapy (Chemotherapy) 10/2019
1	Central Venous Catheters 05/2019
1	Patient Readmission 01/2019
1	Aftercare (After-Treatment) 07/2013
1	Dual Anti-Platelet Therapy 01/2012
1	Ligation 09/2011